Drugs Made In America Acquisition Corp. · NASDAQ:DMAA
Mizuho Financial Group Inc reported a 8.50% stake in Drugs Made In America Acquisition Corp. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
Mizuho Financial Group Inc reported a 8.50% stake in Drugs Made In America Acquisition Corp., 2,058,605 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 8.50%
- Shares
- 2,058,605
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Mizuho Financial Group, Inc. | 8.50% | 2,058,605 |
Source
Related
- Drugs Made In America Acquisition Corp.
- Mizuho Financial Group Inc
- Drugs Made In America Acquisition Corp. shareholders
- Schedule 13G · Mizuho Financial Group Inc · May 14, 2026
- Schedule 13G/A · Karpus Management, Inc. · Aug 14, 2026
- Schedule 13G/A · First Trust Capital Management L.P. · Aug 14, 2026
- Schedule 13G/A · Glazer Capital, LLC · Aug 13, 2026
- Schedule 13G · Feis Equities LLC · Jun 26, 2026
- Schedule 13G/A · Hudson Bay Capital Management LP · Nov 12, 2025